Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells
Open Access
- 23 November 2015
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (39) , 41535-41549
Abstract
Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cellsKeywords
This publication has 52 references indexed in Scilit:
- Airway mesenchymal cell death by mevalonate cascade inhibition: Integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteinsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2014
- Hydrophobic statins induce autophagy and cell death in human rhabdomyosarcoma cells by depleting geranylgeranyl diphosphateEuropean Journal of Pharmacology, 2012
- Aborted Autophagy and Nonapoptotic Death Induced by Farnesyl Transferase Inhibitor and LovastatinThe Journal of Pharmacology and Experimental Therapeutics, 2011
- A small GTPase, human Rab32, is required for the formation of autophagic vacuoles under basal conditionsCellular and Molecular Life Sciences, 2009
- Golgi-resident Small GTPase Rab33B Interacts with Atg16L and Modulates Autophagosome FormationMolecular Biology of the Cell, 2008
- Activation of the Integrated Stress Response Regulates Lovastatin-induced ApoptosisJournal of Biological Chemistry, 2007
- Cholesterol depletion induces autophagyBiochemical and Biophysical Research Communications, 2006
- Simultaneous determination of farnesyl and geranylgeranyl pyrophosphate levels in cultured cellsAnalytical Biochemistry, 2005
- Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington diseaseNature Genetics, 2004
- Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cellsCell Death & Differentiation, 2004